Woolf Tod 4
4 · RXI PHARMACEUTICALS CORP · Filed Jan 20, 2009
Insider Transaction Report
Form 4
Woolf Tod
DirectorPresident and CEO
Transactions
- Award
Stock Option
2009-01-15+48,000→ 420,100 totalExercise: $4.19Exp: 2019-01-15→ Common Stock (48,000 underlying)
Footnotes (3)
- [F1]Granted pursuant to the RXi Pharmaceuticals Corporation 2007 Incentive Plan.
- [F2]Per share.
- [F3]3,000 of the options will vest on April 15, 2009 and the remaining shares will vest in equal installments on each of the next 15 quarterly anniversaries beginning on July 15, 2009.